DOI:
10.1055/s-00034914
Osteologie
LinksClose Window
References
Kachnic LA, Pugh SL, Tai P. et al.
RTOG 0518: randomized phase III trial to evaluate zoledronic acid for prevention
of osteoporosis and associated fractures in prostate cancer patients.
Prostate Cancer Prostatic Dis 2013;
16: 382-386
Access:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.